Qwoted is a free expert network: we help reporters connect with experts & we help those same experts build relationships with top reporters.
Event Date |
Thu Nov 9 GMT - Fri Nov 10 GMT (about 1 year ago)
In your timezone (EST): Wed Nov 8 7:00pm - Thu Nov 9 7:00pm |
Location |
Novotel West London
1 Shortlands Hammersmith International Ctre, London W6 8DR, UK |
Region | EMEA |
Turn digital health’s potential into true business opportunities. The event will bring together digital health change-makers from across the ecosystem to enhance medicine, embed digital solutions, and align with advancing patient care pathways enhance medicine. Digital health promises to be the pinnacle of healthcare’s revolution, empowering pharma to improve patient outcomes and achieve commercial ambition. But we're still tangled in stakeholder uncertainty, hazy go-to-market models, insufficient data capabilities, and a fragmented value chain that prevents our digital health renaissance.
Why you should attend:
• Upskill data capabilities: Equip your organisation with the resources it needs to generate critical data sets that support clinically-valid product development
• Redesign commercialisation: Pull digital health out of its silo and design go-to-market models within therapeutics and drug commercialisation strategies
• Resonate value: Drive digital health acceptance across stakeholders through robust value-driven evidence grounded in clinical efficacy, health economics and improved patient outcomes
• Partner and play: Marry pharma’s strength in scientific innovation with external technology capabilities to secure market share opportunities.
2023 Speakers
Gregoire Guillet
Chief Business and Value Officer, Servier
Yacine Hadjiat
Global Head of Digital Health Solutions, Biogen
Sonny Shergill
VP of Commercial Digital Health, AstraZeneca
Sally Chung
VP, Head of Market Access & Pricing, GSK
Darshan Joshi
Global Head of Data Management, Takeda
Quentin Le Masne
Head of Solution Delivery, Global Digital Health, Merck
Sridevi Nagarajan
Head of Digital Regulatory Strategy, AstraZeneca
Liron Noy
Head of Innovation & Business Excellence, AstraZeneca
Haider Alleg
General Partner, Allegory Capital
Spencer Jones
Senior Digital Health Lead, Bristol Myers Squibb
Andrew Rosen
Senior Director, Integrated Evidence Team Lead, Moderna
Sophie Brachet
Head of Early Commercial & Access, Oncology, Debiopharm
Carmen Jack
Senior Director, Digital Health and Innovation, GSK
Elcie Chan
EU Commercial Director, Digital Health, Otsuka
Valerie Hepp
Digital and PHC Partnering Lead Europe & Asia, Roche
Andrew Smith
Associate Director, Digital Health, Teva